Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Huen

607 Anti-Pruritic Properties of Remetinostat (SHAPE), a Topical Histone Deacetylase Inhibitor (HDACi); Data From a Randomized Phase 2 Study in Patients With Stage IA- IIA Mycosis Fungoides

Journal of Investigative Dermatology

English

DUAL PI3K Δ/Γ INHIBITOR RP6530 IN PATIENTS WITH RELAPSED/REFRACTORY T-Cell LYMPHOMA: DOSE ESCALATION FINDINGS.

Hematological Oncology

English

Related publications

Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009

Cell Death and Disease

Molecular Neuroscience

English

Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers

Cancer Chemotherapy and Pharmacology

English

Solar: A Phase 2, Global, Randomized, Active Comparator Study to Investigate the Efficacy and Safety of Cobomarsen in Subjects With Mycosis Fungoides (Mf)

Hematological Oncology

English

Risk of Cutaneous Malignancy in Mycosis Fungoides Patients Treated With PUVA: A Retrospective Study

Turk Dermatoloji Dergisi

Dermatology

2015

English

Efficacy of Narrowband UVB vs. PUVA in Patients With Early-Stage Mycosis Fungoides

Journal of the European Academy of Dermatology and Venereology

Dermatology

Infectious Diseases

2009

English

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies

Clinical Cancer Research

Cancer Research

Oncology

2006

English

106 Early Stage Mycosis Fungoides Has a Mutanome Distinct From Sezary Syndrome

Journal of Investigative Dermatology

English

Complex Structure of a Bacterial Class 2 Histone Deacetylase Homologue With a Trifluoromethylketone Inhibitor

Acta Crystallographica Section F Structural Biology and Crystallization Communications

2007

English

A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma

Oncotarget

Oncology

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Huen

607 Anti-Pruritic Properties of Remetinostat (SHAPE), a Topical Histone Deacetylase Inhibitor (HDACi); Data From a Randomized Phase 2 Study in Patients With Stage IA- IIA Mycosis Fungoides

DUAL PI3K Δ/Γ INHIBITOR RP6530 IN PATIENTS WITH RELAPSED/REFRACTORY T-Cell LYMPHOMA: DOSE ESCALATION FINDINGS.

Related publications

Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009

Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers

Solar: A Phase 2, Global, Randomized, Active Comparator Study to Investigate the Efficacy and Safety of Cobomarsen in Subjects With Mycosis Fungoides (Mf)

Risk of Cutaneous Malignancy in Mycosis Fungoides Patients Treated With PUVA: A Retrospective Study

Efficacy of Narrowband UVB vs. PUVA in Patients With Early-Stage Mycosis Fungoides

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies

106 Early Stage Mycosis Fungoides Has a Mutanome Distinct From Sezary Syndrome

Complex Structure of a Bacterial Class 2 Histone Deacetylase Homologue With a Trifluoromethylketone Inhibitor

A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma